TALOTTA, Rossella
 Distribuzione geografica
Continente #
NA - Nord America 2.124
EU - Europa 1.422
AS - Asia 759
SA - Sud America 10
AF - Africa 4
OC - Oceania 1
Totale 4.320
Nazione #
US - Stati Uniti d'America 2.114
IE - Irlanda 648
SE - Svezia 414
CN - Cina 326
SG - Singapore 312
IT - Italia 182
IN - India 85
PL - Polonia 30
FI - Finlandia 25
DE - Germania 20
BE - Belgio 19
UA - Ucraina 19
GB - Regno Unito 18
FR - Francia 17
RU - Federazione Russa 12
IQ - Iraq 8
BR - Brasile 7
CA - Canada 7
VN - Vietnam 7
IR - Iran 6
CZ - Repubblica Ceca 4
EG - Egitto 4
BG - Bulgaria 3
DK - Danimarca 3
ES - Italia 3
MX - Messico 3
NL - Olanda 3
TR - Turchia 3
TW - Taiwan 3
CO - Colombia 2
ID - Indonesia 2
KZ - Kazakistan 2
QA - Qatar 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
CL - Cile 1
HK - Hong Kong 1
RO - Romania 1
Totale 4.320
Città #
Dublin 647
Chandler 539
Nyköping 342
Singapore 261
Princeton 149
Dearborn 115
Beijing 113
Jacksonville 112
Medford 112
Ann Arbor 90
Des Moines 84
New York 82
Ashburn 80
Pune 70
Wilmington 41
Cambridge 35
Messina 32
Warsaw 28
Los Angeles 26
Jinan 25
Brussels 19
Nanjing 19
Shenyang 19
Zhengzhou 16
Falls Church 14
Washington 13
Catania 12
Ningbo 12
Boardman 11
Hebei 11
San Mateo 11
Guangzhou 10
Hangzhou 10
Woodbridge 9
Haikou 8
Changsha 7
Grammichele 7
Hyderabad 7
Nanchang 7
Norwalk 7
Dong Ket 6
Milan 6
Seattle 6
Fuzhou 5
Helsinki 5
Lancaster 5
Redwood City 5
Verona 5
Bremen 4
Brno 4
Jiaxing 4
Shanghai 4
Taizhou 4
Tianjin 4
Bengaluru 3
Clifton 3
Florence 3
Gioiosa Marea 3
Hefei 3
Iowa City 3
Itu 3
London 3
Milwaukee 3
Moscow 3
Paris 3
Pisa 3
Reggio Calabria 3
Santa Clara 3
São Paulo 3
Taichung 3
Taiyuan 3
Arco 2
Astana 2
Augusta 2
Bagheria 2
Basrah 2
Bello 2
Brooklyn 2
Buffalo 2
Cagliari 2
Cairo 2
Changle 2
Chengdu 2
Clearwater 2
Dallas 2
Gela 2
Houston 2
Jakarta 2
Kunming 2
Lanzhou 2
Lappeenranta 2
Leeds 2
Lyon 2
Monmouth Junction 2
Nuremberg 2
Plovdiv 2
Redmond 2
Roda 2
San Giorgio a Cremano 2
Shijiazhuang 2
Totale 3.388
Nome #
CORRELATION BETWEEN DISEASE ACTIVITY AND CARDIOVASCULAR PARAMETERS IN PATIENTS WITH ANKYLOSING SPONDYLITIS 77
Densità minerale ossea, parametri ultrasonografici e metabolismo osseo in pazienti affetti da sclerosi sistemica. 75
The microbiome in connective tissue diseases and vasculitides: An updated narrative review 75
SUBCLINICAL HYPERCORTISOLISM IS A RISK FACTOR TO BE EVALUATED IN THE ASSESSMENT OF BONE FRAGILITY? 73
effetti dell'acido ialuronico sulla qualità di vita in pazienti affetti da osteoartrosi 70
Algo-dysfunctional syndromes: a critical digest of the recent literature 70
CARDIOVASCULAR EVALUATION USING NON-INVASIVE IMAGING METHODS IN PATIENTS WITH ANKYLOSING SPONDYLITIS BEFORE AND AFTER 12 MONTHS OF TREATMENT WITH ANTI-TNF DRUGS 69
Densità minerale ossea, parametri ultrasonografici e metabolismo osseo in pazienti affetti da sclerosi sistemica. 68
CORRELATION BETWEEN SERUM LEVELS OF SCL-70 AUTO-ANTIBODIES AND SUBCLINICAL LV SYSTOLIC DYSFUNCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS 68
SYSTEMIC SCLEROSIS AND CHRONIC GRAFT-VERSUS-HOST DISEASE SCLERODERMA-LIKE HAVE OTHER SIMILAR PATHOGENETIC MECHANISMS THAN STIMULATORY AUTOANTIBODIES TO PDGFR? 63
Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab 60
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 59
BODY MASS INDEX, SMOKING STATUS AND RESPONSE TO RITUXIMAB IN RHEUMATOID ARTHRITIS: A REAL-LIFE STUDY. 59
Certainties and uncertainties concerning the contribution of pericytes to the pathogenesis of systemic sclerosis 57
Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors 57
Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases 57
Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents 56
Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases” 53
Differential Diagnosis of Vasovagal Syncope: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. 51
JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future 51
Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical trial 51
CHRONIC PAIN AND DEPRESSION: PAIN THRESHOLD AND VISUAL ANALOGUE SCALE. 50
Biomarkers in Rheumatoid Arthritis 50
CLINICAL AND ULTRASONOGRAPHIC EVALUATION IN A COHORT OF SUSTAINED REMISSION RHEUMATOID ARTHRITIS PATIENTS AFTER STOPPING BIOLOGIC THERAPY: A SINGLE CENTER EXPERIENCE , 50
Immunogenicity and autoimmunity during anti-TNF therapy 49
Safety and Efficacy of Switching from Originator to CT-P13 Infliximab Biosimilar in Patients Affected By Spondyloarthritis. a 6-Month Observational Study 49
Ultrasonographyc Evaluation of Metacarpophalangeal Joints Can be Useful in the Differential Diagnosis of Early Rheumatoid Arthritis and Early Spondyloarthritis. A Monocentric Preliminary Study 49
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum 49
Influence of polymorphism -308 G/A of the TNF-α gene on high mobility group BOX-1 protein in rheumatoid and spondylo-arthritis patients 48
From autoinflammation to autoimmunity: old and recent findings 47
Patologie respiratorie allergiche e miceti: casistica personale. 46
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: A case series 46
Patients Failing to Fulfill 2016 Criteria for Fibromyalgia Represent a Truly Different Population Subset 46
Autoimmunity as the comet tail of COVID-19 pandemic 46
The rationale for targeting the JAK/STAT pathway in scleroderma-associated interstitial lung disease 46
Influence of Polymorphism at Position-308 of the Tumour Necrosis Factor Alpha Gene on the Expression of High Mobility Group Box-1 Protein in Rheumatoid Arthritis and Spondyloarthritis patient. 45
THE THRESHOLD OF PAIN IN PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS CORRELATES WITH ESR BUT NOT WITH ULTRASOUND SCORE. 45
MEASUREMENT OF SERUM ALPHA-KLOTHO IN SYSTEMIC SCLEROSIS PATIENTS: RESULTS FROM A PIVOTAL STUDY. 44
Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back? 44
Riniti persistenti da un punto di vista immunologico 43
Measurement of Serum Klotho in Systemic Sclerosis 43
One year in review 2019: fibromyalgia 43
Retrotransposons shuttling genetic and epigenetic information from the nuclear to the mitochondrial compartment: Do they play a pathogenetic role in scleroderma? 43
The contribution of HERV-E clone 4-1 and other HERV-E members to the pathogenesis of rheumatic autoimmune diseases. 43
Calcium physiology, metabolism and supplementation: a glance at patients with ankylosing spondylitis 43
Motor cortex tRNS improves pain, affective and cognitive impairment in patients with fibromyalgia: preliminary results of a randomised sham-controlled trial 43
ACHILLES PAIN PERSISTENCE IN PATIENTS AFFECTED BY SPONDYLOARTHRITIS: ULTRASONOGRAPHIC AND BIOMECHANICAL STUDY. 42
Physical activity in idiopathic inflammatory myopathies: two intervention proposals based on literature review 42
THE CORRELATION BETWEEN CTLA4, CD80 AND CD86 GENE POLYMORPHISMS AND CLINICAL RESPONSE IN PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT. 41
DOSE REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RESPONDING TO THE STANDARD RITUXIMAB REGIMEN. 41
Biological agents in rheumatoid arthritis: A cross-link between immune tolerance and immune surveillance 40
Efficacy and Safety of Biosimilar and Originator Etanercept in Rheumatoid Arthritis Patients: Real-Life Data 40
The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis 39
What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis? 39
GENISTEIN PREVENTS QUALITY OF LIFE OSTEOPENIC POST- MENOPAUSAL WOMENS: A 2-YEAR RANDOMIZED, DOUBLE-BLIND, CONTROLLED-STUDY. 38
Skin scores of patients with systemic sclerosis correlate with circulating thyrotropin levels 37
Reactivation of occult hepatitis B virus infection under treatment with abatacept: A case report 37
Infections and Biological Therapy in Patients with Rheumatic Diseases 37
Earthquake vulnerability of fibromyalgia patients: six-month follow-up after the catastrophic disasters in central Italy 37
PAIN INTENSITY AND THRESHOLD IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS PATIENTS: CORRELATIONS WITH THE HAMILTON DEPRESSION RATING SCALE 37
RELATIONSHIP BETWEEN ULTRASONOGRAPHIC SALIVARY GLANDS ABNORMALITIES AND SUBCLINICAL CARDIOVASCULAR INVOLVEMENT IN PATIENTS WITH PRIMARY SJÖGREN SYNDROME 37
Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response 36
Investigating the potential side effects of anti-TNF therapy for rheumatoid arthritis: cause for concern? 36
Pain in systemic sclerosis 36
Reasons Why Patients Failed Vaccinations Vs Influenza and Pneumococcus. Monocentric Cross-Sectional Study 36
Retroviruses in the pathogenesis of systemic lupus erythematosus: Are they potential therapeutic targets? 36
Vitamin D levels and bone mineral density in systemic sclerosis 34
Psoriatic arthritis: From pathogenesis to pharmacologic management 34
Prevalence of hepatitis B virus infection and risk of reactivation in rheumatic population undergoing biological therapy 34
Perspectives: potential therapeutic approach with inhalation of ACE2-derived peptides for SARS-CoV-2 infection 34
Rheumatic Diseases and Biosimilars: Evidence about Switch from Originators to Biosimilars in the Real Life 33
Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study 32
SDAI AS PREDICTOR OF 1-YEAR EFFICACY OF THE FIRST TNF BLOCKER IN CLINICAL PRACTICE. 32
Glucocorticoidi nell’artrite reumatoide ed esperienze cliniche dell’uso di prednisone a rilascio modificato 32
VITAMIN D LEVELS AND BONE MINERAL DENSITY IN SYSTEMIC SCLEROSIS. 31
PREVALENCE OF CHRONIC WIDESPREAD PAIN IN SSC PATIENTS: PRELIMINARY DATA 31
Efficacy of Cannabis Flos in Patients with Fibromyalgia: A Monocentric 30
Possible relationship between certolizumab pegol and arrhythmias: Report of two cases 29
Novel pharmaceutical options for treating fibromyalgia 29
The role of klotho in systemic sclerosis 28
IL RUOLO DI KLOTHO NELLA SCLEROSI SISTEMICA 27
null 26
Pros and cons of the immunogenicity of monoclonal antibodies in cancer treatment: A lesson from autoimmune diseases 26
Spondyloarthritis and Gastrointestinal Involvement 26
EXPRESSION OF HERV-E CLONE 4.1 GAG TRANSCRIPTS IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS 26
The preventive and therapeutic role of physical activity in knee osteoarthritis 26
Ultrasonographic Evaluation of the Enthesis in Patients Affected By Entheropatic Spondiloarthritis. Focus on Distal Enthesis of the Patellar Tendon 25
PARADOXICAL EXPANSION OF TH1 AND TH17 CELLS IN PERIPHERAL CULTURAL BLOOD CELLS OF RA PATIENTS FOLLOWING INFLIXIMAB TREATMENT: A POSSIBLE CORRELATION WITH LOSS OF CLINICAL RESPONSE AND ADVERSE EVENTS 25
Polymorphic alleles in Exon 1 of the CTLA4 gene do not predict the response to abatacept. 24
THE ROLE OF TH9 LYMPHOCYTES IN RHEUMATOID ARTHRITIS 24
Evaluation of salivary and plasma microRNA expression in patients with Sjogren's syndrome, and correlations with clinical and ultrasonographic outcomes 24
FATIGUE IN FIBROMYALGIA REFLECTS OVERALL BURDEN OF DISEASE 24
Pain Intensity and Threshold in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients: Correlations with the Hamilton Depression Rating Scale 23
Fibromialgia 23
Serum klotho concentrations inversely correlate with the severity of nailfold capillaroscopic patterns in patients with systemic sclerosis 22
null 22
PREVALENCE AND EPIDEMIOLOGY OF FAMILIAL MEDITERRANEAN FEVER AND TUMOR NECROSIS FACTORRECEPTOR-ASSOCIATED PERIODIC SYNDROME: RESULTS FROM AN ITALIAN CENTER 22
Pamidronate Treatment of Osteonecrosis of the Hip in Young Male. 21
One year in review 2017: fibromyalgia. 21
SEQUENCE COMPLEMENTARITY BETWEEN SARS-CoV-2 GENOME AND HUMAN NONCODING RNAS ASSOCIATED WITH IMMUNOLOGICAL DISORDERS: AN IN SILICO PIVOTAL STUDY 21
Totale 4.154
Categoria #
all - tutte 24.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.382


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020474 0 0 0 0 0 72 202 37 10 63 62 28
2020/2021463 18 7 109 19 112 24 35 53 16 38 19 13
2021/2022666 5 38 17 27 43 17 42 33 14 36 35 359
2022/20231.895 148 195 124 153 71 192 34 105 796 11 49 17
2023/2024516 44 56 19 35 40 195 2 16 6 32 8 63
2024/2025449 42 15 38 164 132 58 0 0 0 0 0 0
Totale 4.642